LA LUCIDA ANALISI FATTA COME SEMPRE da Roy de Vita. Ascoltate chi c'è sempre stato dietro la FDA e anche per EMA ed AIFA c'è il solito marciume. MASSIMA CONDIVISIONE!!! THE CLEAR ANALYSIS MADE AS ALWAYS by Roy de Vita. Listen to those who have always been behind the FDA and also for EMA and AIFA there is the usual rot. MAXIMUM SHARING!!! #RobertKennedyJr: La Sanità americana dovrebbe essere affidata a lui. Panico nelle file avverse - Roy de Vita #roydevita #fda #fdagate #modernagate

Il governo della Provincia Autonoma di Bolzano contrario alla revisione critica delle misure Covid – continua a negare persino fatti istituzionalmente confermati e cerca di non farmi dire la verità nel Consiglio Provinciale, minacciando la mia espulsione dall‘Aula! 👇👇👇 https://www.renate-holzeisen.eu/it/comunicato-stampa-17/?amp=1 Il Governo provinciale dell’Alto Adige – in primis l’Assessore responsabile della salute degli altoatesini Hubert Messner – non ha alcuna intenzione di attuare una revisione critica delle misure pandemiche, revisione che è – invece – essenziale per il futuro. E questo nonostante una promessa nel programma di governo. L’assessore Messner continua a sostenere che i cosiddetti “vaccini” Covid-19 sarebbero stati autorizzati per la prevenzione dell’infezione virale e quindi per l’inibizione della trasmissione del virus! Da ultimo, rispondendo ad una delle mie interrogazioni, che evidentemente danno fastidio alla Giunta provinciale, in Aula del Consiglio Provinciale lo scorso 5.11.2024. Riguardava, tra le altre, la mia interrogazione sui motivi per i quali il Governo provinciale dell’Alto Adige non ha concesso (come confermato dall’Assessore competente Ulli Mair) agli inquilini “non-vaccinati” contro il Covid-19 di un appartamento dell’IPES (Istituto Provinciale dell’Edilizia Sociale) – che si trovano in difficoltà finanziari< a causa della sospensione dal lavoro senza retribuzione per tanti mesi – la riduzione dell’affitto sociale a cui per legge provinciale hanno diritto tutti coloro che si trovano in difficoltà economiche senza colpa, nonchè sui motivi  per i quali a questi inquilini poi è stato addirittura disdetto dall’IPES il contratto di affitto. https://drive.google.com/file/d/1Rd2fOysZeAroqu3QPNyQaXJ5vcEhUHNy/view?usp=drivesdk Nella sua risposta alla mia interrogazione, l’Assessore Messner ha ripetuto una volta di più la gravissima disinformazione – diffusa dai politici sin dalla fine del dicembre 2020 – e secondo la quale i cosiddetti “vaccini” Covid-19 sarebbero stati autorizzati per la prevenzione dell’infezione virale e quindi per l’inibizione della trasmissione virale – e che quindi non vi sarebbe stato alcun uso off-label (cioè al di fuori dall’indicazione terapeutica del “vaccino”) sui  cittadini obbligati a vaccinarsi ai fini della prevenzione del contagio con il virus SARS-CoV-2. E ciò nonostante il fatto che il contrario emergesse in modo inequivocabile sin dall’inizio dai documenti di autorizzazione all’immissione in commercio e ora viene confermato anche da tribunali italiani! Poiché anche l’EMA e l’AIFA hanno confermato che i cosiddetti “vaccini” Covid-19 non sono mai stati autorizzati per la prevenzione del contagio virale, ci possono essere solo due ragioni per la diffusione di falsità da parte dell’Assessore Messner: o l’Assessore Messner non è in grado di leggere i documenti ufficiali di autorizzazione dei farmaci ed è affetto da una dissonanza cognitiva persino rispetto a conferme esplicite da parte dell’EMA e dell’AIFA, oppure sta cercando di coprire il proprio irresponsabile operato degli ultimi anni, continuando a diffondere una eclatante disinformazione. Entrambe le situazioni sono inaccettabili per un medico, ex primario e ora Assessore alla Salute. Va ricordato che Hubert Messner si dichiarò favorevole pure alla “vaccinazione” Covid-19 dei bambini al fine di una presunta “immunità di gregge”! È evidente che Hubert Messner è incorso in una enorme responsabilità personale per aver consigliato il trattamento di bambini e adolescenti con sostanze sperimentali pericolose (miocardite, morte indicati tra i possibili effetti collaterali anche nel foglietto illustrativo!) e che non sono mai state autorizzate allo scopo di inibire la trasmissione del virus, come invece da lui ancora oggi sostenuto! E ovviamente tenta di sottrarsi a questa grave responsabilità negando pure l’innegabile! 👇👇👇 Qui ulteriori dettagli scandalosi anche sul fatto che cercano di non farmi dichiarare in Consiglio Provinciale la Verità!

https://www.decidim.barcelona/profiles/abroad_gateway80/activity https://www.rcuniverse.com/forum/members/abroadgateway80.html https://gifyu.com/abroadgateway80 https://slides.com/abroadgateway80 https://topbazz.com/Abroadgateway80 https://about.me/gateway80 https://www.lanikaibrewing.com/profile/abroadgateway80/profile https://www.nutrociencia.com.br/profile/abroadgateway80/profile https://www.ikraupvc.co.id/profile/abroadgateway80/profile https://www.recentstatus.com/Abroadgateway80 https://jobs.njota.org/profiles/5541481-abroad-gateway80 https://pastewall.com/43642/wall/1 http://molbiol.ru/forums/index.php?showuser=1398999 https://www.in-pocasi.cz/uzivatele/abroadgateway80-127916/

CAR T Cell Therapy Market Emerging Trend, Opportunities, Key Players, Huge Growth, Revenue Analysis, 2023-2035 The latest report entitled ‘CAR T Cell Therapy Market’ by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe. The current global CAR T-cell therapy market size is likely to be worth USD 4.6 billion, and is projected to reach worth USD 15.2 billion by 2035, growing at a CAGR of 11.4% during the period, till 2035. The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies currently adopted by them. The report is a granular assessment of this particular business sphere and entirely covers the dynamic competitive landscape of the market. The document offers key insights into the market positions of these players alongside their gross earnings. Furthermore, it elaborates on each of the market segments, with detailed scrutiny of the development scope and competitive scenario of the regional fragments of the market. The latest study is inclusive of an in-depth analysis of the economic status of the CAR T Cell Therapy Market and examines the most important regions constituting the global market. It further details on the most lucrative and growth-oriented regions, top market rivals, diversified product types, and a large number of end-use industries. Key factors affecting the growth of the CAR T Cell Therapy Market: Geographical Overview: • The latest report broadly categorizes the CAR T Cell Therapy Market into several geographical terrains, including North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa and Rest of the World. • The study is inclusive of essential information relevant to each region in this broad industry segment, along with the key drivers of the regional market growth. • The report further estimates the revenue accumulated by these regions over the forecast period. Competitive Hierarchy: • The latest research report studies the major market players, their regional presence, industry share, and production facilities. • The report offers significant data pertaining to these market competitors’ company profiles, product types, and application outlook. • Moreover, the pricing models and gross margins of these industry majors have also been mentioned in the report. Key players Autolus, Bluebird Bio, Bristol Myers Squibb, Carsgen Therapeutics, Cellectis, Gilead Sciences, Innovative Cellular Therapeutics, Noile-Immune Biotech, Novartis, Shanghai GeneChem, Sinobioway Cell Therapy, Takara Bio and Wellington Zhaotai Therapies. Additional parameters of the CAR T Cell Therapy Market report: • The latest research study endows the reader with a comprehensive analysis of the product types of the CAR T Cell Therapy Market, categorizing the relevant information into the Distribution by Target Inidcation, Target Antigens and Key Geographical Regions. The study focuses on the wide-ranging application landscape of the market, segmenting it into the market share, estimated growth rate, and the forecast product demand for each application type. Additional Insights: • The market concentration rate and processing rate of raw materials have also been conscripted in the report. • The report contains an assessment of the current price trends, as well as the factors influencing the global market size. • It throws light on the significant marketing strategies implemented by the eminent players in the industry. • Vital data and information concerning the producers, distributors, and downstream buyers involved in the global market, as well as the cost structure analysis and market mechanism, form the important elements of this report. Research objectives: • The CAR T Cell Therapy Market report studies the worldwide market consumption rate in terms of value and volume. • It identifies the various sub-segments of the market structure. • It proffers information regarding the leading global manufacturers in this industry, describing their market value & share, sales volume, competitive analysis, SWOT analysis, and development strategies adopted during the forecast timeline. • The report describes the key industry players, with respect to their individual growth trends, future prospects, and contribution to the global market, and explains the factors related to their market growth potential, drivers, opportunities, threats, and industry-specific challenges. • Furthermore, the report underpins the strategic developments occurring in the CAR T Cell Therapy Market, such as expansions, mergers & acquisitions, agreements, as well as new product launches. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/car-t-cell-therapy-market/269.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way. The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide. Contact: Roots Analysis +1 (415) 800 3415 Sales@rootsanalysis.com

The Advantages of China CA Zn Stabilizer in PVC Applications The China CA Zn stabilizer is revolutionizing the PVC industry with its exceptional properties and environmentally friendly profile. This calcium-zinc-based stabilizer offers a non-toxic alternative to traditional lead stabilizers, making it an ideal choice for manufacturers prioritizing sustainability. One of the standout features of the CA Zn stabilizer is its remarkable thermal stability. It enables PVC products to endure high processing temperatures without degrading, resulting in enhanced mechanical properties such as improved tensile strength and flexibility. This robustness makes it suitable for a wide range of applications, including pipes, profiles, and films, where durability is essential. In addition to its performance benefits, the CA Zn stabilizer ensures excellent color stability and transparency, enhancing the aesthetic appeal of final products. Its compatibility with various processing methods allows manufacturers to streamline production while maintaining high-quality standards. As industries increasingly focus on eco-friendly practices, the China CA Zn stabilizer is emerging as a go-to solution for producing safe, durable, and attractive PVC products. By integrating this innovative stabilizer into their formulations, manufacturers can meet both performance and environmental standards, positioning themselves as leaders in sustainable manufacturing. https://www.zjhongtian.com/product/

32000 Medici pagati dalle case farmaceutiche.pdf CERCATE NEL FILE. TROVERETE DELLE SORPRESE.

The research analysis on the global Sterilization Equipment Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Sterilization Equipment Market circumstances in the forecast period between 2024 and 2031. The global Sterilization Equipment Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Read More @ https://www.skyquestt.com/report/sterilization-equipment-market

https://linkingdirectory.com/author/abroadgateway81-17775/ https://www.7cups.com/@Abroadgateway81 https://fitinline.com/profile/abroadgm3/ https://seedly.sg/profile/abroad-gateway-d2b96323-694e-47e8-8256-5b66cbedae27/ https://jobs.windomnews.com/profiles/4955276-abroad-gateway https://collectednotes.com/abroadgateway81/unknown https://www.mothering.com/members/abroadgateway81.477334/#about https://uplink.weforum.org/uplink/s/profile/005TE000004XhtW https://www.dnxjobs.de/users/Abroadgateway81 https://submitarticlesblog.com/author/abroadgateway81/ https://buildd.co/u/abroad_gateway_975 https://pitchwall.co/user/abroadgateway81 https://www.ubertheme.com/profile/abroadgateway81/ http://idea.informer.com/users/Abroadgateway81/?what=personal https://fstoppers.com/profile/abroadgateway81 https://www.inflearn.com/users/@abroadgateway https://vietfones.vn/forum/members/abroadgateway81.250788/ https://www.fundable.com/abroad-gateway-1 https://developer.cisco.com/user/profile/e799deef-0be3-5922-9801-7691c490b6dc https://www.curioos.com/abroadgateway81 https://www.myminifactory.com/users/abroadgateway2 https://files.fm/abroadgateway81 https://maxternmedia.com/author/abroadgateway81 https://opencollective.com/abroad-gateway https://biomolecula.ru/authors/30428 https://www.zerohedge.com/user/tZNamnV0LXVDWw4e9ambNzIe54D3 https://bootstrapbay.com/user/Abroadgateway81 https://robertsspaceindustries.com/citizens/Abroadgateway81 https://www.scenario.press/Abroadgateway81

Brain Health Supplements Market Global outlook 2024 to 2031 The research analysis on the global Brain Health Supplements Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Brain Health Supplements Market circumstances in the forecast period between 2024 and 2031. Read More @ https://www.skyquestt.com/report/brain-health-supplements-market

Infection Control Market Overview: A lot of factors, such as geographic growth, segmentation, and market size by value and volume, are taken into account in the SkyQuest Technology Group research to provide a full and accurate analysis of the global Infection Control market. This outstanding research study was created specifically to provide the most latest data on significant aspects of the global Infection Control Industry. Numerous market estimates are provided in the analysis, including those for market size, output, revenue, consumption, CAGR, gross margin, price, and other critical factors. The best primary and secondary research methods and tools on the Infection Control market were used to build it. Numerous research studies are included in it, including ones on pricing analysis, production and consumption analysis, company profile, and manufacturing cost analysis. Global Infection Control Market size was valued at USD 45.31 billion in 2022 and is poised to grow from USD 48.17 billion in 2023 to USD 78.52 billion by 2031, growing at a CAGR of 6.3% in the forecast period (2024-2031). Chance to get a free sample @ https://www.skyquestt.com/sample-request/infection-control-market